Mezzanotte-Sharpe J, ONeill A, Mayer IA, Arteaga CL, et al. A randomized phase III double-blind placebo-controlled trial of first-line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105). Breast Cancer Res Treat 2024 Jul 5. doi: 10.1007/s10549-024-07417.
PMID: 38967884